Tianda Pharmaceuticals Ltd. | Cash Flow
Fiscal year is April-March. All values HKD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
48,949.30
23,016.30
13,367.20
32,749.70
29,942.00
Depreciation, Depletion & Amortization
17,927.70
18,943.30
21,089.60
21,391.10
22,041.90
Other Funds
28,104.90
1,260.40
28,013.30
11,444.10
13,649.80
Funds from Operations
68,821.50
4,975.00
32,602.00
43,835.10
31,642.20
Changes in Working Capital
2,943.10
759.60
12,916.30
2,136.20
26,283.20
Net Operating Cash Flow
65,878.40
5,734.60
19,685.70
45,971.30
57,925.30
Capital Expenditures
28,764.40
35,331.80
3,680.70
2,803.00
8,639.40
Sale of Fixed Assets & Businesses
-
25.00
313.00
0.40
26.60
Purchase/Sale of Investments
-
-
30,046.00
-
32,904.00
Net Investing Cash Flow
37,523.90
8,588.50
74,272.70
2,802.50
18,925.40
Cash Dividends Paid - Total
7,667.50
4,488.30
-
5,806.70
10,487.30
Net Financing Cash Flow
35,772.40
3,227.90
81,265.50
17,250.80
24,186.70
Net Change in Cash
7,634.00
16,681.70
10,116.00
5,014.90
88,881.90
Free Cash Flow
37,809.30
41,019.60
16,407.00
43,168.30
49,291.10
Net Assets from Acquisitions
-
-
-
-
5,365.80
Other Sources
-
940,546.40
-
-
-
Change in Capital Stock
-
-
109,278.80
-
49.60
Exchange Rate Effect
216.10
869.20
16,562.50
20,903.00
36,217.80
Other Uses
8,759.50
913,828.10
40,858.90
-
-
About Tianda Pharmaceuticals
View Profile
